Gilead Sciences, Inc.
Macrocyclic inhibitors of flaviviridae viruses
Last updated:
Abstract:
Provided are compounds of Formula I: ##STR00001## and pharmaceutically acceptable salts and esters thereof. The compounds, compositions, and methods provided are useful for the treatment of virus infections, particularly hepatitis C infections.
Status:
Grant
Type:
Utility
Filling date:
2 Feb 2017
Issue date:
12 Nov 2019